Skip to content

Funding Announcements

Filter

Filter & sort

Keyword

Tag

Round

Sort by

Clear

The latest funding rounds from the UK tech ecosystem. Updated 4 November 2026.

Announcements

6,263

Total raised

£165B

disclosed amounts

This month

£177M

raised so far

Seed
£1.0M

The routing and navigation specialists exceeded their initial target by closing a campaign backed by existing shareholders, angels and the public.

"We are delighted with the support shown for our recent Seedrs campaign; closing the campaign with 126% of our target is excellent and highlights the public’s desire for smarter and safer routing technology"
— Mark Jenner, Co-founder
Other
€1.1M

The funding round was led by Furthr VC to support job creation and global growth.

"We are delighted to receive this funding from our investors, who share our excitement for the future of Ronspot. The team at Furthr VC have been working closely with us, offering valuable advice as we prepare for a period of rapid global growth."
— Michael Furey, CEO
Series B
£14.7M

The virtual fertility clinic raised funds from MTIP and Iris Ventures to accelerate international expansion and technology development.

"MTIP’s deep-rooted understanding of the healthcare landscape combined with Iris Ventures’ expertise in the consumer space will be invaluable as Apricity enters its next stage of growth and we expand into more regions."
— Caroline Noublanche, Founder and CEO
Series A
£2.2M

Foresight Group led the investment round with participation from angel backers to support the expansion of the company radiology technology.

"We are very pleased to have closed this round following extraordinary levels of interest where we were oversubscribed. There has been an explosion of early stage healthtech funding across Europe, but we think that Hexarad has connected with investors because we are developing healthcare technology that truly addresses the biggest issues facing healthcare providers. Our first-hand experience of the pressure that radiology departments are under means that we are uniquely placed to develop innovative, clinically-led solutions"
— Farzana Rahman, Co-Founder and CEO